Matrix metalloproteinase-3 is activated by HtrA2/Omi in dopaminergic cells: relevance to Parkinson's disease

Neurochem Int. 2012 Feb;60(3):249-56. doi: 10.1016/j.neuint.2012.01.001. Epub 2012 Jan 11.

Abstract

Dopaminergic neurons in the substantia nigra are particularly vulnerable, and their degeneration leads to Parkinson's disease. We have previously reported that matrix metalloproteinase-3 (MMP-3) activity is involved in dopaminergic neurodegeneration by multiple mechanisms and that this requires activation of MMP-3 from proMMP-3 by an intracellular serine protease. HtrA2/Omi is a mitochondrial serine protease that has been shown in non-dopaminergic cells to translocate into the cytosol where it triggers apoptosis. In the present study we sought to determine whether HtrA2/Omi might cause activation of MMP-3 in dopaminergic neuronal cells using CATH.a cell line. Mitochondrial stress induced by rotenone led to MMP-3 activation and HtrA2/Omi translocation into the cytosol. The MMP-3 activation involved HtrA2/Omi, because both pharmacological inhibition and siRNA-induced knockdown of HtrA2/Omi attenuated the activation induced by rotenone or MPP+. Overexpression of mature HtrA2/Omi, but not mutant HtrA2/Omi, resulted in MMP-3 activity increase and cell death. Addition of recombinant and catalytically active HtrA2/Omi to lysate of untreated cells led to activation of the endogenous MMP-3, and incubation of the HtrA2/Omi with recombinant proMMP-3 caused cleavage of proMMP-3 to a 48kD protein, corresponding to the active form, which was accompanied by an increase in MMP-3 activity. Taken together, the data indicate that HtrA2/Omi, which normally exists in the mitochondria, can cause MMP-3 activation in the cytosol under a cell stress condition, which can ultimately lead to demise of dopaminergic neuronal cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Western
  • Cell Death
  • Cytosol / drug effects
  • Cytosol / enzymology
  • Dopaminergic Neurons / enzymology*
  • Enzyme Activation / physiology
  • Humans
  • Immunohistochemistry
  • L-Lactate Dehydrogenase / analysis
  • L-Lactate Dehydrogenase / metabolism
  • Matrix Metalloproteinase 3 / metabolism*
  • Mitochondria / drug effects
  • Mitochondria / enzymology
  • Nerve Tissue Proteins / antagonists & inhibitors
  • Nerve Tissue Proteins / genetics*
  • Nerve Tissue Proteins / physiology*
  • Parkinson Disease / enzymology*
  • RNA / biosynthesis
  • RNA / genetics
  • RNA, Small Interfering / genetics
  • RNA-Binding Proteins / antagonists & inhibitors
  • RNA-Binding Proteins / genetics*
  • RNA-Binding Proteins / physiology*
  • Real-Time Polymerase Chain Reaction
  • Rotenone / pharmacology
  • Serine-Arginine Splicing Factors
  • Silver Staining
  • Subcellular Fractions / metabolism
  • Transfection
  • Uncoupling Agents / pharmacology
  • X-Linked Inhibitor of Apoptosis Protein / metabolism

Substances

  • Nerve Tissue Proteins
  • RNA, Small Interfering
  • RNA-Binding Proteins
  • TRA2B protein, human
  • Uncoupling Agents
  • X-Linked Inhibitor of Apoptosis Protein
  • Rotenone
  • Serine-Arginine Splicing Factors
  • RNA
  • L-Lactate Dehydrogenase
  • Matrix Metalloproteinase 3